ID16778A - Turunan 2-(3h)-okasazolon baru - Google Patents

Turunan 2-(3h)-okasazolon baru

Info

Publication number
ID16778A
ID16778A IDP970904A ID970904A ID16778A ID 16778 A ID16778 A ID 16778A ID P970904 A IDP970904 A ID P970904A ID 970904 A ID970904 A ID 970904A ID 16778 A ID16778 A ID 16778A
Authority
ID
Indonesia
Prior art keywords
turunan
okasazolon
baru
okasazolon baru
Prior art date
Application number
IDP970904A
Other languages
English (en)
Indonesian (id)
Inventor
Carles Puig Duran
Ferran Pujol Noguera
Dolors Fernandez Forner
Original Assignee
Grupo Farmaceutico Almirall S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8294266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16778(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grupo Farmaceutico Almirall S filed Critical Grupo Farmaceutico Almirall S
Publication of ID16778A publication Critical patent/ID16778A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP970904A 1996-03-21 1997-03-20 Turunan 2-(3h)-okasazolon baru ID16778A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009600685A ES2125161B1 (es) 1996-03-21 1996-03-21 Nuevos derivados de 2-(3h)-oxazolona.

Publications (1)

Publication Number Publication Date
ID16778A true ID16778A (id) 1997-11-13

Family

ID=8294266

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970904A ID16778A (id) 1996-03-21 1997-03-20 Turunan 2-(3h)-okasazolon baru

Country Status (29)

Country Link
US (1) US6869968B1 (cs)
EP (1) EP0888316B1 (cs)
JP (1) JP3810091B2 (cs)
KR (1) KR100496395B1 (cs)
CN (1) CN1110488C (cs)
AR (1) AR006340A1 (cs)
AT (1) ATE197294T1 (cs)
AU (1) AU713811B2 (cs)
BR (1) BR9708141A (cs)
CA (1) CA2249420A1 (cs)
CO (1) CO4780046A1 (cs)
CZ (1) CZ294963B6 (cs)
DE (1) DE69703437T2 (cs)
DK (1) DK0888316T3 (cs)
ES (2) ES2125161B1 (cs)
GR (1) GR3035096T3 (cs)
ID (1) ID16778A (cs)
IL (1) IL126206A (cs)
NO (1) NO311761B1 (cs)
NZ (1) NZ331901A (cs)
PE (1) PE42898A1 (cs)
PL (1) PL188722B1 (cs)
PT (1) PT888316E (cs)
RU (1) RU2194043C2 (cs)
TW (1) TW426674B (cs)
UA (1) UA52645C2 (cs)
UY (1) UY24499A1 (cs)
WO (1) WO1997034882A1 (cs)
ZA (1) ZA972203B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
ES2131015B1 (es) * 1997-09-12 2000-03-01 Almirall Prodesfarma Sa Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
ES2168895A1 (es) * 1999-03-26 2002-06-16 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
ES2154561B1 (es) * 1998-09-25 2001-12-01 Almirall Prodesfarma Sa Derivados de 2-fenilpiran-4-ona.
PT1175214E (pt) 1999-12-08 2005-04-29 Pharmacia Corp Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
EP1539679A4 (en) 2002-06-28 2007-07-04 Nitromed Inc OXIM- AND / OR HYDRAZO-CONTAINING, NITROSED AND / OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND USE METHODS
ES2215474B1 (es) 2002-12-24 2005-12-16 J. URIACH & CIA S.A. Nuevos derivados de fosforamida.
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
WO2004098619A2 (en) 2003-05-07 2004-11-18 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
CN1309717C (zh) * 2003-06-03 2007-04-11 李小虎 4－芳基－5h－噻吩－2－酮衍生物、其制法和用途
RU2270673C1 (ru) * 2004-08-17 2006-02-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" (ГОУ ВПО СибГМУ) Способ реабилитации больных после операции на щитовидной железе
US20100111858A1 (en) * 2007-01-19 2010-05-06 Howard Carol P Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
ZW19786A1 (en) * 1985-10-17 1988-05-18 Hoffmann La Roche Heterocyclic compounds
US4866182A (en) 1988-02-18 1989-09-12 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoyl and aroyl oxazolones
US5380738A (en) 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
DE4435547A1 (de) 1994-10-05 1996-04-11 Bayer Ag Sulfonylaminocarbonyltriazolinone mit über Sauerstoff und Schwefel gebundenen Substituenten
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
FR2753449B1 (fr) 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique

Also Published As

Publication number Publication date
AR006340A1 (es) 1999-08-25
JP2000506876A (ja) 2000-06-06
MX9701944A (es) 1998-06-30
DE69703437T2 (de) 2001-03-08
CN1218459A (zh) 1999-06-02
PE42898A1 (es) 1998-08-12
HK1015371A1 (en) 1999-10-15
DK0888316T3 (da) 2000-11-27
CO4780046A1 (es) 1999-05-26
UA52645C2 (uk) 2003-01-15
ATE197294T1 (de) 2000-11-15
JP3810091B2 (ja) 2006-08-16
KR20000064727A (ko) 2000-11-06
CN1110488C (zh) 2003-06-04
ZA972203B (en) 1997-09-25
IL126206A0 (en) 1999-05-09
CZ297998A3 (cs) 1999-02-17
KR100496395B1 (ko) 2005-09-27
AU2289397A (en) 1997-10-10
BR9708141A (pt) 1999-07-27
IL126206A (en) 2001-06-14
PL328915A1 (en) 1999-03-01
PT888316E (pt) 2001-02-28
NO311761B1 (no) 2002-01-21
UY24499A1 (es) 1997-04-02
ES2151254T3 (es) 2000-12-16
DE69703437D1 (de) 2000-12-07
CA2249420A1 (en) 1997-09-25
AU713811B2 (en) 1999-12-09
ES2125161A1 (es) 1999-02-16
PL188722B1 (pl) 2005-04-29
ES2125161B1 (es) 1999-11-16
NO984325D0 (no) 1998-09-17
GR3035096T3 (en) 2001-03-30
NZ331901A (en) 1999-10-28
WO1997034882A1 (en) 1997-09-25
TW426674B (en) 2001-03-21
NO984325L (no) 1998-11-23
RU2194043C2 (ru) 2002-12-10
CZ294963B6 (cs) 2005-04-13
US6869968B1 (en) 2005-03-22
EP0888316A1 (en) 1999-01-07
EP0888316B1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
ID17686A (id) Fotoinisiator alpha-aminoasetofenon baru
ID17053A (id) Derivat-derivat 2-(2-okso-etiliden)-imidazolidin-4-on
ID21881A (id) Turunan-turunan baru pirazol tersubstitusi
ID15840A (id) Turunan-turunan 19-nor-pregnena baru
ID17149A (id) Senyawa baru 2,3 tersubstitusi-4 (3h)-kuinazolinon
ID27263A (id) Dihidropirimidina baru
ID16660A (id) Senyawa-senyawa b-laktam monosiklik baru
ID18759A (id) Imidazole tersubstitusi sikloalkil baru
ID15880A (id) Bentuk baru heteroaril oksazolidinon-oksazolidinon
ID17873A (id) Penghambat trombin baru
ID16778A (id) Turunan 2-(3h)-okasazolon baru
ID18431A (id) Senyawa-senyawa baru
ID26299A (id) Herbisida baru
DE59705155D1 (de) Kalander
ID24208A (id) Piridin-piridin pensubtitusi 2-amino baru
ID19542A (id) Pengobatan baru
ID18262A (id) Turunan-turunan baru piranosida
DE59705507D1 (de) Kalander
ID16247A (id) Metode baru
ID19433A (id) Senyaw-senyawa baru
ID24191A (id) Komposisi baru
ID16684A (id) Senyawa-senyawa sulfonilurea baru
ID22144A (id) Senyawa-senyawa baru
ID18889A (id) Senyawa baru
FI972881A0 (fi) Kuidutusmenetelmä